Perspective
Published on 23 Jan 2025
Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1433999
- 1,344 views
Type at least 3 characters
551 articles
Review
Published on 10 Jan 2025
A systematic review and meta-analysis of the effects of combined aripiprazole on glycolipid metabolism in schizophrenia
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1496986
- 933 views
Correction
Published on 23 Dec 2024
Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1523364
- 414 views
Original Research
Published on 20 Dec 2024
Clinical pharmacist recommendations in daily interdisciplinary ward rounds at a psychiatric hospital: a retrospective pre-post study on drug-related problems focused in somatic comorbidities
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1473832
- 663 views
Original Research
Published on 09 Dec 2024
Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1471457
- 892 views
Systematic Review
Published on 09 Dec 2024
Phytochemicals in the treatment of patients with depression: a systemic review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1509109
- 2,096 views
Case Report
Published on 04 Dec 2024
Pregabalin treatment in a 30-year-old patient with Bainbridge-Ropers syndrome: a case-report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1502773
- 1,448 views
- 1 citation
Systematic Review
Published on 04 Dec 2024
Prevalence and solving strategies of drug-related problems in adult psychiatric inpatients - a systematic review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1460098
- 1,107 views
Opinion
Published on 12 Nov 2024
Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1491417
- 2,544 views
- 1 citation
Editorial
Published on 12 Nov 2024
Editorial: Women in psychiatry 2023: psychopharmacology
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1488260
- 484 views
Case Report
Published on 07 Nov 2024
Vortioxetine as an alternative treatment for somatic symptom disorder: case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1496072
- 2,282 views
- 1 citation
Opinion
Published on 06 Nov 2024
Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1485337
- 3,254 views
Original Research
Published on 01 Nov 2024
Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium from the FDA Adverse Event Reporting System, 2017–2023
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1442490
- 2,007 views
Editorial
Published on 22 Oct 2024
Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1494444
- 1,051 views
Original Research
Published on 14 Oct 2024
Hepatotoxicity of antipsychotics: an exploratory pharmacoepidemiologic and pharmacodynamic study integrating FAERS data and in vitro receptor-binding affinities
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1479625
- 1,506 views
Original Research
Published on 04 Oct 2024
Passiflora incarnata L., herba, in benzodiazepine tapering: long-term safety and efficacy in a real-world setting
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1471083
- 1,851 views
- 1 citation